Deep Phenotyping Reveals Distinct Immune Signatures Correlating with Prognostication, Treatment Responses, and MRD Status in Multiple Myeloma.
Papadimitriou K, Tsakirakis N, Malandrakis P, Vitsos P, Metousis A, Orologas-Stavrou N, Ntanasis-Stathopoulos I, Kanellias N, Eleutherakis-Papaiakovou E, Pothos P, Fotiou D, Gavriatopoulou M, Kastritis E, Dimopoulos MA, Terpos E, Tsitsilonis OE, Kostopoulos IV.
Papadimitriou K, et al. Among authors: dimopoulos ma.
Cancers (Basel). 2020 Nov 4;12(11):3245. doi: 10.3390/cancers12113245.
Cancers (Basel). 2020.
PMID: 33158030
Free PMC article.